Ulcerative Colitis Clinical Trial Opportunity

If you or someone you know is living with Ulcerative Colitis (UC), there’s an opportunity to contribute to medical advancements. A clinical research study, sponsored by Merck, is currently enrolling adults with moderate-to-severe active UC to test an investigational medicine.

Understanding Ulcerative Colitis (UC)

Ulcerative Colitis is a chronic condition characterized by inflammation within the colon. It’s a common form of inflammatory bowel disease (IBD) affecting about 1 million Americans. While the exact cause is unknown, it’s believed to stem from the body’s immune system mistakenly attacking healthy tissues. Common symptoms include diarrhea, abdominal pain, fatigue, blood in the stool, nausea, and sudden weight loss.

The ATLAS-UC Study: How to Participate

The ATLAS-UC study is investigating the safety and potential effectiveness of an investigational medicine for individuals with moderate-to-severe active UC. Researchers are looking for participants who meet specific criteria, including being between 16 and 75 years old and having a diagnosis of moderate-to-severe active UC.

• Receive the investigational study medicine or a placebo at no cost.
• Undergo study-related medical exams free of charge.
• Potentially receive reimbursement for travel-related study expenses, such as bus fare or gas.

It’s important to note that participants may or may not directly benefit from being in the study. The study doctor will be available to discuss any questions you may have regarding the potential risks and benefits of participation.

The Importance of Diversity in Clinical Research

LaShanda Gordon, clinical trial diversity program lead at Merck, emphasizes the critical role of diversity in clinical trials. “Different people may have different reactions to the same treatment based on their age, gender, weight, race, ethnicity and other factors,” she stated. Ensuring that trials include a diverse range of participants is essential for generating data that accurately reflects the experiences of all individuals affected by a disease, including Ulcerative Colitis.

If you’re interested in learning more or believe you might be eligible, the next step is to speak with your doctor. They can help determine if participation in the ATLAS-UC study is the right choice for you. For more detailed information, you can visit www.merckclinicaltrials.com/ulcerativecolitistrial.